ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,972Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 51

$632K Total Retail Price of All Prescriptions

Rank: 1 out of 51

429 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in District of Columbia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

8% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 9,824 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $73 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in District of Columbia
LISINOPRIL 972 786 1 1
AMLODIPINE BESYLATE 621 431 2 2
FUROSEMIDE 557 470 3 4
HYDROCHLOROTHIAZIDE 548 425 4 8
SIMVASTATIN 490 368 5 6
ATORVASTATIN CALCIUM 326 255 6 5
METOPROLOL TARTRATE 324 251 7 9
NIFEDIPINE ER 310 294 8 21
METFORMIN HCL 310 232 8 10
WARFARIN SODIUM 218 172 10 14
CLONIDINE HCL 214 138 11 26
POTASSIUM CHLORIDE 185 136 12 37
IBUPROFEN 177 113 13 32
CARVEDILOL 177 112 13 7
HYDRALAZINE HCL 173 143 15 17
METOPROLOL SUCCINATE 169 122 16 3
DIOVAN 169 126 16 16
ATENOLOL 158 119 18 26
OMEPRAZOLE 155 118 19 22
PLAVIX 141 113 20 15
DIGOXIN 137 112 21 23
NEXIUM 134 107 22 33
CLOPIDOGREL 126 115 23 13
GABAPENTIN 121 105 24 40
VENTOLIN HFA 121 93 24 57
COLCRYS 120 107 26 45
LOSARTAN POTASSIUM 118 112 27 11
TRIAMTERENE-HCTZ 116 94 28 30
LANTUS 114 59 29 62
ZOLPIDEM TARTRATE 104 46 30 34
NAPROXEN 103 90 31 49
RANITIDINE HCL 103 92 31 69
NITROGLYCERIN PATCH 97 77 33 70
PROAIR HFA 97 85 33 46
ISOSORBIDE MONONITRATE ER 92 58 35 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 57 36 28
TAMSULOSIN HCL 83 59 37 54
ADVAIR DISKUS 82 73 38 49
GLIPIZIDE 82 63 38 38
CYCLOBENZAPRINE HCL 80 41 R 40 52
KLOR-CON M20 79 75 41 55
ACETAMINOPHEN-CODEINE 78 68 S3 42 19
INSULIN SYRINGE 76 39 43 75
LIPITOR 74 62 44 41
LEVETIRACETAM 73 36 45 76
SPIRIVA 71 68 46 77
ALENDRONATE SODIUM 70 70 47 51
KLOR-CON M10 70 67 47 53
CRESTOR 70 57 47 12
BENICAR 67 61 50 58
PRAVASTATIN SODIUM 63 37 51 24
LANTUS SOLOSTAR 61 41 52 82
RANEXA 61 57 52 59
ZETIA 60 27 54 39
GLIPIZIDE ER 60 56 54 84
AZITHROMYCIN 59 44 56 48
OXYCODONE-ACETAMINOPHEN 58 30 S2 57 31
SPIRONOLACTONE 56 38 58 20
LEVOTHYROXINE SODIUM 56 55 58 35
COMBIVENT 55 27 60 87
BYSTOLIC 54 35 61 36
SINGULAIR 52 35 62 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.